38 results on '"Hamid, Nadira"'
Search Results
2. HEMODYNAMIC PERFORMANCE OF THE JENAVALVE TRILOGY™ SYSTEM FROM THE ALIGN-AR TRIAL - THE FIRST DEDICATED TRANSCATHETER AORTIC VALVE FOR AORTIC REGURGITATION.
3. NOVEL MODELING FOR PATIENT SPECIFIC PREDICTION OF TECHNICAL SUCCESS FOLLOWING MITRACLIPTMINTERVENTION - A NEURAL SYSTEM DYNAMICS ANALYSIS FROM THE COAPT TRIAL.
4. COMMISSURAL ALIGNMENT AFTER TRANSFEMORAL DELIVERY OF THE JENAVALVE TRANSCATHETER AORTIC VALVE.
5. NOVEL MODELING FOR PATIENT SPECIFIC PREDICTION OF TECHNICAL SUCCESS FOLLOWING MITRACLIPTMINTERVENTION - A NEURAL SYSTEM DYNAMICS ANALYSIS FROM THE COAPT TRIAL.
6. COMMISSURAL ALIGNMENT AFTER TRANSFEMORAL DELIVERY OF THE JENAVALVE TRANSCATHETER AORTIC VALVE.
7. RELATIONSHIP OF COMPUTED TOMOGRAPHY ANNULAR OVERSIZING AND IMPLANT DEPTH TO NEW PERMANENT PACEMAKER IMPLANTATION AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT FOR NATIVE AORTIC VALVE REGURGITATION USING THE JENAVALVE TRILOGY SYSTEM: INSIGHTS FROM THE ALIGN AR TRIAL
8. ASSOCIATION OF COMPUTED TOMOGRAPHY OVERSIZING WITH PVL RATES WITH A DEDICATED TRANSCATHETER AORTIC VALVE FOR NATIVE AORTIC VALVE REGURGITATION USING THE JENAVALVE TRILOGY SYSTEM: INSIGHTS FROM THE ALIGN AR TRIAL.
9. ASSESSMENT OF BALLOON-EXPANDABLE TRANSCATHETER HEART VALVE OVERSIZING USING THREE-DIMENSIONAL TRANSESOPHAGEAL ECHOCARDIOGRAPHY SEMI-AUTOMATION VERSUS. DIRECT PLANIMETRY: ALL METHODS ARE NOT CREATED EQUAL.
10. EFFECTIVE ORIFICE AREA REFERENCE VALUES WITH THE DIFFERENT SIZES OF THE SAPIEN 3 BALLOON-EXPANDING TRANSCATHETER AORTIC VALVE.
11. TCT-327 Calcium Volume Score on Contrast-Enhanced Computed Tomography Prior to Transcatheter Aortic Valve Replacement: what’s the most accurate threshold cutoff?
12. Deep Learning Electrocardiographic Analysis for Detection of Left-Sided Valvular Heart Disease.
13. MULTI-VESSEL PCI AND CABG DEMONSTRATE SIGNIFICANT IMPROVEMENTS IN POST-PROCEDURE GLOBAL LONGITUDINAL STRAIN AND LEFT VENTRICULAR EJECTION FRACTION.
14. LEFT VENTRICULAR REMODELING AFTER JENAVALVE TRILOGY TRANSCATHETER AORTIC VALVE REPLACEMENT IN PATIENTS WITH PURE AORTIC REGURGITATION.
15. TCT-138 Right Ventricular Remodeling and Clinical Outcomes Following Transcatheter Tricuspid Valve Intervention.
16. TCT-95 TEE- and Fluoroscopy-Guided WATCHMAN Implantation Without Administration of Iodinated Contrast Material.
17. INCIDENCE, PREDICTORS, AND OUTCOMES OF UNPLANNED CORONARY ANGIOGRAPHY AFTER TRANSCATHETER AORTIC VALVE REPLACEMENT.
18. TCT-467 DurAVR Biomimetic Transcatheter Aortic Valve: First-in-Human Study Results Update.
19. Restructuring Structural Heart Disease Practice During the COVID-19 Pandemic: JACC Review Topic of the Week.
20. TCT-413 Frequency and Feasibility of Unplanned Coronary Angiography After Transcatheter Aortic Valve Replacement.
21. ANNULUS ASSESSMENT PRIOR TO TRANSCATHETER AORTIC VALVE REPLACEMENT: ANNULUS DIMENSIONS MAY NOT BE LARGEST IN MID-SYSTOLE.
22. TCT-471 First-in-Human Study Results With the Novel Anteris DurAVRTM Three-Dimensional Single-Piece TAVR Device.
23. Acute changes in mitral annular geometery after Mitraclip procedure in functional and degenerative mitral regurgitation.
24. THE ABSENCE OF SEVERE CORONARY STENOSIS (≥70%) ON CORONARY COMPUTED TOMOGRAPHIC ANGIOGRAPHY RELIABLY EXCLUDES MODERATE TO SEVERE ISCHEMIA ON MYOCARDIAL PERFUSION IMAGING
25. TCT-297 Accelerated Left Atrial Appendage Closure With the New-Generation WATCHMAN FLX by CCTA at 45 Days Postimplant.
26. TCT-255 Net Adverse Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement With a History of Remote, Recent, or Concurrent Percutaneous Coronary Intervention.
27. IMPACT OF POSTIMPLANT THERAPY ON CLINICAL OUTCOMES IN ATRIAL FIBRILLATION PATIENTS RECEIVING TRANSCATHETER LEFT ATRIAL APPENDAGE CLOSURE.
28. PERIDEVICE LEAK AND DEVICE SIZING IN PATIENTS RECEIVING LEFT ATRIAL APPENDAGE CLOSURE WITH THE WATCHMAN DEVICE.
29. 30-DAY OUTCOMES OF TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT FOR AORTIC REGURGITATION WITH A NOVEL SELF-EXPANDING PROSTHESIS.
30. IMPACT OF POSTIMPLANT THERAPY ON CLINICAL OUTCOMES IN ATRIAL FIBRILLATION PATIENTS RECEIVING TRANSCATHETER LEFT ATRIAL APPENDAGE CLOSURE.
31. PERIDEVICE LEAK AND DEVICE SIZING IN PATIENTS RECEIVING LEFT ATRIAL APPENDAGE CLOSURE WITH THE WATCHMAN DEVICE.
32. 30-DAY OUTCOMES OF TRANSFEMORAL TRANSCATHETER AORTIC VALVE REPLACEMENT FOR AORTIC REGURGITATION WITH A NOVEL SELF-EXPANDING PROSTHESIS.
33. REFERRAL PATTERNS FOR PULMONARY EMBOLISM (PE) PATIENTS AT A TERTIARY ACADEMIC MEDICAL CENTER: INSIGHTS INTO PULMONARY EMBOLISM RESPONSE TEAM (PERT) UTILIZATION AND PATIENT OUTCOMES.
34. UNVEILING OUTCOMES IN COEXISTING SEVERE AORTIC STENOSIS AND TRANSTHYRETIN CARDIAC AMYLOIDOSIS.
35. TCT-88 6-Month Outcomes of an Early Feasibility Study of the AccuCinch Left Ventricular Repair System in Patients With Heart Failure and Functional Mitral Regurgitation.
36. THE MYOCARDIAL CONTRACTION FRACTION IS SUPERIOR TO THE VOLTAGE TO MASS RATIO FOR IDENTIFYING TTR CARDIAC AMYLOID IN PATIENTS UNDERGOING TAVR.
37. TRANSTHYRETIN CARDIAC AMYLOIDOSIS IS PREVALENT AMONG MEN WITH SEVERE AORTIC STENOSIS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT.
38. THE EFFECT OF OVERSIZING ON THE HEMODYNAMIC PERFORMANCE OF THE SAPIEN 3 TRANSCATHETER HEART VALVE.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.